VaccineSTATS: Vaccine Pipeline/IP review (CAT No: VAVS016)Published by: VacZine Analytics Published: Oct. 1, 2012 Table of Contents
AbstractThis analysis of the VacZine Analytics online R&D pipeline database focuses primarily on pathogens for which no vaccines are currently available. The objectives are to 1) Identify active clinical and preclinical projects, categorized by major market segment (Infant/adolescent, Sexually transmitted diseases, Insect borne/endemic diseases and Adult/elderly), 2) Compare and contrast the vaccine pipelines of the main multinational vaccine companies (MNCs) including GSK Biologicals, Merck & Co, Novartis Vaccines, Sanofi Pasteur and Pfizer and 3) Assess which vaccine segments/pathogens have the highest R&D interest to identify where companies may compete and grow. The vaccine R&D pipeline database contains around 280 validated entries of active commercial vaccine programs covering over 100 companies. It can be used for competitive intelligence, business development and strategic planning activities.Get full details about this report >> |
|
|
|
About MarketResearch.com
|
||

